Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-077336
Filing Date
2026-06-24
Accepted
2026-06-24 16:52:56
Documents
12

Document Format Files

Seq Description Document Type Size
1 424B5 tm2618428-2_424b5.htm 424B5 655026
2 EX-FILING FEES tm2618428d2_ex-filingfees.htm   iXBRL EX-FILING FEES 26540
3 GRAPHIC lg_uniqure-4c.jpg GRAPHIC 27275
  Complete submission text file 0001104659-26-077336.txt   847856

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2618428d2_ex-filingfees_htm.xml XML 4998
Mailing Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM Netherlands 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284168 | Film No.: 261116610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)